Skip to content

SouthwardTech

Technology, industry and investment across China and the Global South

5 projects tracked1 Contracted4 AnnouncedReviewed

Global South

Where does AI fit in the pharmacy? A case from Vietnam

Long Châu describes using AI to organise customer conversations before pharmacists take over, offering a glimpse of how the technology can fit into everyday service.

For some older customers of Vietnam’s Long Châu pharmacy chain, buying medicine brings a practical request: staying in touch with a pharmacist afterwards, without having to install another app. That is how Trần Xuân Nam, e-commerce director at the chain’s operator, FPT Retail, explained their interest in its official account on Zalo, a messaging platform. The scale explains why sorting matters: Nam said Long Châu had built a base of 20 million followers or users interested in its Zalo official account, linked to customer touchpoints across about 2,800 sales locations, according to VietnamPlus.

Speaking at an industry event in Ho Chi Minh City on 21 October, Nam described how the chain handles conversations through that account, according to VietnamPlus’s report published on 29 October. This is where AI enters the service: helping organise customer enquiries before pharmacists take over.

The workflow combines data labels, a customer-data platform and AI to help classify conversations. A customer-data platform is software for organising customer information. Once enough information is available, the conversation passes to a pharmacist, the report said.

The Zalo case is not the chain's first use of AI in pharmacy service. It announced an AI-assisted medication-reminder feature in August 2024. MarketTimes reported in August 2026 that the company claimed accuracy of up to 98% for AI recognition of handwritten prescriptions. It has also used an AI Mentor to personalise pharmacist training, according to the supplier, FPT AI.

In the Zalo conversation workflow, AI has a specific supporting role. A customer has contacted the pharmacy, and the enquiry needs to reach someone who can respond. Sorting messages is one part of that process; understanding whether the handover contains useful information is another. The published account does not explain who decides that enough information has been gathered or what triggers the transfer.

Pharmacists make the final decision, according to an event recap published by organiser Insider One. The role described for AI is to help organise an enquiry, with the pharmacist taking over to respond. That makes the connection between the two stages central to understanding how the service works. At the event, a Zalo executive said business data remained owned by the business and customer samples uploaded for advertising audience matching were encrypted. These are platform assurances; the account did not describe the data controls applied during AI classification and handover of pharmacy conversations.

For a customer, the quality of that handover would matter as much as the sorting itself. A useful assessment would ask whether the pharmacist receives enough relevant information to respond, whether the customer has to repeat their enquiry and how quickly they reach someone who can help.

For the chain, the potential benefit is a more manageable flow of enquiries and less repetitive work for pharmacists. Any saving would need to be weighed against time spent clarifying or correcting information at the handover. For this Zalo conversation workflow, the published accounts provide no before-and-after figures for waiting times, staff workload, errors or costs. The practical test is whether customers get useful answers sooner, with less work needed along the way.

Published 5 November 2026 · Last updated 31 October 2026 · Corrections to corrections@southwardtech.com

Weekly newsletter

The Southward Brief

A weekly briefing on the technologies, companies and industrial shifts reshaping China and the Global South.

Required. Enter a valid email address.

By subscribing, you agree to receive The Southward Brief. You can unsubscribe at any time. Read our Privacy Policy.